通心络对急性冠状动脉综合征患者血浆C-反应蛋白和内皮素-1的影响

目的 探讨通心络胶囊对急性冠状动脉综合征(ACS)患者血浆C-反应蛋白(CRP)和内皮素-1(ET-1)的影响.方法 将100例ACS患者随机分为常规组和通心络组(常规治疗+通心络胶囊),观察治疗前及第7、14天血浆CRP和ET-1的变化.结果 与治疗前相比,第7、14天通心络组血浆CRP和ET-1水平均显著下降,差异有统计学意义(P＜0.05、P＜0.01);而常规组仅第14天有显著变化,与治疗前比较差异有统计学意义(P＜0.05).通心络组CRP和ET-1水平与常规组比较差异有统计学意义(P＜0.01).结论 通心络可能通过抑制CRP和ET-1减少血管内膜的炎症反应等途径改善血管内皮功能,从而达到对血管内皮的保护作用.

Effect of Tongxinluo capsule on the plasma C-reactive protein and endothelin-1 in acute coronary syndrome patients

Objective To study the effect of Tongxinluo on the plasma C-reactive protein(CRP)and endothelin-1(ET-1)in acute coronary syndrome(ACS) patients.Methods 100 patients with ACS were randomly divided into conventional therapy group and treatment group(conventional therapy+Tongxinluo gelatin capsule).The changes of CRP and ET-1 in the first day,7th and 14th day were observed.Results In the treatment group,CRP and ET-1 were significantly decreased in the 7th and 14th day(P＜0.05,P＜0.01),and there was significant decrease only in the 14th day(P＜0.05)in the conventional therapy group.CRP and ET-1 levels in the treatment group were significantly different as compared with conventional thereapy group(P＜0.01).Conclusion Tongxinluo capsule may protect blood vessel endothelium through inhibiting CRP and ET-1 to decrease the inflammatory response of endangium.